NovoLog Mix 70/30
- Product NDC
- 50090-4085
- 11-digit product format
- 500904085
- Labeler code
- 50090
- Product ID
- 50090-4085_a15ae450-ec81-47e4-803f-25b511223261
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- insulin aspart
- Dosage form
- INJECTION, SUSPENSION
- Route
- SUBCUTANEOUS
- Labeler
- A-S Medication Solutions
- Application
- BLA021172
- Marketing category
- BLA
- Marketing start
- 2002-09-11
- Marketing end
- 0000-00-00
- Substance
- INSULIN ASPART
- Active strength
- 100 [iU]/mL
- Pharmacologic classes
- Insulin [CS],Insulin Analog [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 50090-4085 | D | Discontinued by firm | 2026-09-14 | ||
| excluded package | package | 50090-4085 | 50090-4085-0 | D | Discontinued by firm | 2026-09-14 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 24eab60a-55c8-40c1-8c86-7ed01a7a8bef | Product name | 1 | 20240227 |
| 09fb02dd-baf0-4f67-b464-599bf26324b6 | Product name | 2 | 20200323 |
| 6a6ef80c-37d6-4e02-aa78-fce7b811234e | Product name | 2 | 20200323 |
| 91ae268d-ee0f-6988-629d-5065a4376a50 | Product name | 2 | 20200323 |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-4085-0 | NOVOLOG MIX 70/30 | 3 mL in 1 SYRINGE, PLASTIC | INJECTION, SUSPENSION | 3 | 6 | |
| 50090-4085-0 | NOVOLOG MIX 70/30 | 5 in 1 CARTON | INJECTION, SUSPENSION | 5 | 6 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-4085-0 | ML - Milliliter | 50090-4085 | be1f19fc-0c2f-4094-8178-59da414b12a2 | 1 | 2022-01-06 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-4085 | NOVOLOG MIX 70/30 (INSULIN ASPART) INJECTION, SUSPENSION [A-S MEDICATION SOLUTIONS] | 6 | Legacy NDC, 2 package rows | 20240125_ead74453-dd15-4836-8ad6-5b14ac168d02.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| NovoLog Mix 70/30 | INSULIN ASPART | REMEDYREPACK INC. | 66da64f7-ca50-47d2-95fa-de37005eef85 | 2026-05-18 | Warnings, Adverse reactions | BLA021172 |
| Insulin Aspart Protamine and Insulin Aspart Mix 70/30 | INSULIN ASPART | REMEDYREPACK INC. | 5d9f0e10-edb9-4960-bd62-cf406e75bbe7 | 2026-04-07 | Warnings, Adverse reactions | BLA021172 |
| NovoLog Mix 70/30 | INSULIN ASPART | A-S Medication Solutions | 19888a44-b330-462a-864d-338c5893dd63 | 2026-01-29 | Warnings, Adverse reactions | BLA021172 |
| .Insulin Aspart Protamine and Insulin Aspart | INSULIN ASPART | A-S Medication Solutions | 14499781-b90e-47d5-a7de-006965439b94 | 2024-02-22 | Warnings, Adverse reactions | BLA021172 |
| Insulin Aspart Protamine and Insulin Aspart Mix 70/30 | INSULIN ASPART | Novo Nordisk Pharma, Inc. | fc94baa4-3606-48bc-a781-9617ab6960ef | 2023-02-28 | Warnings, Adverse reactions | BLA021172 |
| NovoLog Mix 70/30 | INSULIN ASPART | Novo Nordisk | 1861fcee-7673-4afe-a206-08fa05c0add2 | 2023-02-28 | Warnings, Adverse reactions | BLA021172 |
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 021172 | Novolog Mix 70/30 | insulin aspart protamine and insulin aspart | 351(a) | Rx | 2026-08-01 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 847191 | insulin aspart protamine / insulin aspart 70/30 in 3 ML Pen Injector | PSN | ead74453-dd15-4836-8ad6-5b14ac168d02 | 6 |
| 977840 | NovoLOG Mix 70/30 in 3 ML Pen Injector | PSN | ead74453-dd15-4836-8ad6-5b14ac168d02 | 6 |
| 977840 | 3 ML insulin aspart protamine, human 70 UNT/ML / insulin aspart, human 30 UNT/ML Pen Injector [NovoLog Mix] | SBD | ead74453-dd15-4836-8ad6-5b14ac168d02 | 6 |
| 847191 | 3 ML insulin aspart protamine, human 70 UNT/ML / insulin aspart, human 30 UNT/ML Pen Injector | SCD | ead74453-dd15-4836-8ad6-5b14ac168d02 | 6 |
| 847191 | insulin, aspart protamine, human 70 UNT/ML / insulin, aspart, human 30 UNT/ML per 3 ML Pen Injector | SY | ead74453-dd15-4836-8ad6-5b14ac168d02 | 6 |
| 977840 | NovoLog Mix 70/30 per 3 ML Pen Injector | SY | ead74453-dd15-4836-8ad6-5b14ac168d02 | 6 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 50090-4085-0 | 50090408500 | 5 SYRINGE, PLASTIC in 1 CARTON (50090-4085-0) > 3 mL in 1 SYRINGE, PLASTIC | 2019-01-25 | 0000-00-00 | No | No | Current |